



Both Duromine and Panbesy contain the same active ingredient (phentermine hydrochloride) and work identically to suppress appetite. The main distinctions are typically:
Ultimately, both are equally effective when prescribed, monitored, and reviewed by a doctor as part of a structured weight-management plan.

Phentermine is typically prescribed for adults with a Body Mass Index (BMI) of 27 kg/m² or higher, especially if they also have medical conditions such as elevated cholesterol, high blood pressure, or sleep-related breathing issues. In selected cases, patients with a BMI between 25 and 27 may also qualify if they present risk factors for metabolic diseases.
During the initial consultation, the doctor will assess:
This thorough evaluation ensures the medication is prescribed safely and only to suitable candidates.
Certain individuals are advised not to take phentermine due to medical contraindications. It should be avoided by patients with:
People with kidney or liver impairment, or those above 60 years of age, should use it only under strict medical supervision. Self-prescribing or purchasing these medications online poses serious health risks and is not allowed under Singapore’s regulations.

At WeightLossClinic.sg, every patient undergoes a detailed medical assessment before being prescribed phentermine. This includes checking cardiovascular health, reviewing potential side effects such as insomnia or palpitations, and determining the most appropriate starting dose.
Our clinic protocol includes:
This evidence-based approach ensures phentermine (Duromine / Panbesy) is used responsibly, in accordance with local HSA and MOH prescribing standards.
In Singapore, phentermine is available in capsule form under brand names such as Duromine and Panbesy. Both contain the same active ingredient, phentermine hydrochloride, in varying strengths designed to suit different patient profiles. These medications are classified as prescription-only appetite suppressants and should be taken strictly under medical supervision.
A proper understanding of dosage and administration is essential to achieve safe and effective results while minimising potential side effects.
Phentermine capsules are most commonly available in 15 mg, 30 mg, and 40 mg modified-release (MR) formulations. These capsules are designed to gradually release the active ingredient throughout the day to provide sustained appetite control without excessive stimulant effects.
Dosage is determined based on individual body weight, response to treatment, and the presence of other medical conditions. It is not advisable to adjust the dose without consulting a doctor.
Phentermine (Duromine / Panbesy) is intended for short-term use, typically over a period of 3 to 12 weeks. The exact duration depends on the patient’s progress, tolerance, and clinical response. Long-term use is generally not recommended due to the potential for tolerance or dependence.
During therapy, doctors will schedule follow-up reviews to assess:
If the patient responds well and tolerates the medication, the doctor may continue treatment for a short, controlled period. Once discontinued, patients are encouraged to sustain their progress through a structured lifestyle plan to prevent rebound weight gain.
Proper adherence to dosage instructions and regular medical supervision are key to maximising benefits and minimising risks from phentermine use.
Phentermine, available under Duromine and Panbesy in Singapore, is prescribed primarily for appetite suppression. When used correctly under medical supervision, it helps reduce hunger, minimise cravings, and support adherence to a calorie-controlled diet. The degree of benefit varies between individuals, but many patients experience improved control over meal portions and reduced snacking tendencies within the first days of therapy.
This medication is not a standalone weight-loss solution. Instead, it forms part of a structured plan that includes dietary adjustments, activity recommendations, and regular medical follow-up.
The main therapeutic effect of phentermine is reduced appetite through its action on appetite-regulating centres in the brain. Most patients report:
These changes help create the consistent caloric reduction necessary for gradual and medically safe weight loss.

Patients usually begin to notice appetite-suppressing effects within 2 to 4 days of starting phentermine. This early response helps set the foundation for improved dietary adherence. Weight reduction may start to become noticeable within the first 2 to 3 weeks, depending on lifestyle adjustments and baseline metabolic factors.
Maximum benefit is often observed between weeks 4 and 8, which corresponds with the typical duration of medical therapy. Continued results depend on maintaining healthy eating patterns and appropriate energy intake after the medication course ends.
During follow-up consultations, the doctor will monitor:
This assessment helps determine whether dosage adjustments are required and ensures that treatment remains both effective and safe. It also provides an opportunity to reinforce dietary habits and activity goals to support long-term weight stability.
Phentermine, including formulations such as Duromine and Panbesy, is generally well tolerated when used under proper medical supervision. However, because it acts on the central nervous system, some individuals may experience side effects. These effects are usually mild and temporary, especially during the initial days of treatment, but close monitoring is recommended.
Commonly reported side effects include:
Most symptoms improve as the body adjusts to the medication. Patients who continue to experience discomfort should inform their doctor so that the dosage can be reviewed or adjusted.
More serious effects are uncommon but require immediate attention. These may include shortness of breath, chest discomfort, severe mood changes, or palpitations. Patients are advised not to continue the medication if such symptoms occur and to seek medical evaluation promptly.
Phentermine may interact with certain medications and medical conditions. To ensure safe treatment, all current prescriptions, supplements, and underlying health issues should be disclosed during the consultation.
Important drug interactions include:
Combining phentermine with any of these agents may increase cardiovascular strain or overstimulation. Alcohol consumption should also be avoided due to the risk of enhanced side effects.
Contraindications include:
Patients with kidney or liver impairment, or older adults, may require closer monitoring or alternative treatment options. A full medical evaluation helps ensure that phentermine is prescribed safely and appropriately.








